Enveric Biosciences Overview
- Year Founded
-
1994
- Status
-
Public
- Employees
-
26
- Stock Symbol
-
ENVB
- Investments
-
10
- Share Price
-
$1.67
- (As of Tuesday Closing)
Enveric Biosciences General Information
Description
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.
Contact Information
Website
www.enveric.comCorporate Office
- 4851 Tamiami Trail North
- Suite 200
- Naples, FL 34103
- United States
Corporate Office
- 4851 Tamiami Trail North
- Suite 200
- Naples, FL 34103
- United States
Enveric Biosciences Stock Performance
As of 25-Mar-2025, Enveric Biosciences’s stock price is $1.67. Its current market cap is $3.21M with 1.92M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.67 | $1.75 | $1.13 - $17.85 | $3.21M | 1.92M | 2.84M | -$36.30 |
Enveric Biosciences Financials Summary
As of 30-Sep-2024, Enveric Biosciences has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 735 | (1,249) | (16,028) | 12,015 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (9,494) | (16,858) | (19,517) | (55,740) |
| Net Income | (9,856) | (17,311) | (18,504) | (48,977) |
| Total Assets | 4,790 | 4,300 | 19,553 | 26,719 |
| Total Debt | 0 | 0 | 64 | 176 |
Enveric Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Enveric Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Enveric Biosciences Patents
Enveric Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230255900-A1 | Compositions for topical treatment of radiation dermatitis | Active | 11-Feb-2022 | ||
| US-12059393-B2 | Compositions for topical treatment of radiation dermatitis | Active | 11-Feb-2022 | ||
| US-11660348-B1 | Cannabinoid conjugate molecules | Active | 01-Feb-2022 | ||
| US-11883499-B2 | Cannabinoid conjugate molecules | Active | 01-Feb-2022 | ||
| US-20230039887-A1 | Compositions for topical treatment of radiation dermatitis | Inactive | 20-Jul-2021 | A61K9/0014 |
Enveric Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Enveric Biosciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Enveric Biosciences Acquisitions (10)
Enveric Biosciences’s most recent deal was a Merger/Acquisition with MagicMed Industries for . The deal was made on 16-Sep-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MagicMed Industries | 16-Sep-2021 | Merger/Acquisition | Drug Discovery | ||
| Jay Pharma | 30-Dec-2020 | Merger/Acquisition | Pharmaceuticals | ||
| ATCG Solutions | 10-Mar-2017 | Merger/Acquisition | IT Consulting and Outsourcing | ||
| Bigtech Software | 23-Sep-2016 | Merger/Acquisition | Business/Productivity Software | ||
| DC&M Partners | 01-Aug-2016 | Merger/Acquisition | Consulting Services (B2B) |
Enveric Biosciences Exits (1)
Enveric Biosciences’s most recent exit was on 25-Jul-2016 from Ameri100 Virtuoso. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Ameri100 Virtuoso | 25-Jul-2016 | Completed |
|
Enveric Biosciences FAQs
-
When was Enveric Biosciences founded?
Enveric Biosciences was founded in 1994.
-
Where is Enveric Biosciences headquartered?
Enveric Biosciences is headquartered in Naples, FL.
-
What is the size of Enveric Biosciences?
Enveric Biosciences has 26 total employees.
-
What industry is Enveric Biosciences in?
Enveric Biosciences’s primary industry is Drug Discovery.
-
Is Enveric Biosciences a private or public company?
Enveric Biosciences is a Public company.
-
What is Enveric Biosciences’s stock symbol?
The ticker symbol for Enveric Biosciences is ENVB.
-
What is the current stock price of Enveric Biosciences?
As of 25-Mar-2025 the stock price of Enveric Biosciences is $1.67.
-
What is the current market cap of Enveric Biosciences?
The current market capitalization of Enveric Biosciences is $3.21M.
-
What is Enveric Biosciences’s annual earnings per share (EPS)?
Enveric Biosciences’s EPS for 12 months was -$36.30.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
